Preludin (phenmetrazine) in the treatment of obesity.
作者信息
MARTEL A
出版信息
Can Med Assoc J. 1957 Jan 15;76(2):117-20.
Abstract
摘要
相似文献
1
Preludin (phenmetrazine) in the treatment of obesity.安非拉酮（苯甲吗啉）治疗肥胖症
Can Med Assoc J. 1957 Jan 15;76(2):117-20.
2
[Preludin (phenmetrazine) in the treatment of obesity].[普律定（苯甲吗啉）用于治疗肥胖症]
Laval Med. 1957 Jan;22(1):45-53.
3
[Symptomatology of obesity in childhood and management with preludin].
Kinderarztl Prax. 1956 Oct;24(10):443-8.
4
The use of phenmetrazine hydrochloride (preludin) in the obese diabetic.盐酸苯甲曲秦（速达肥）在肥胖糖尿病患者中的应用。
Can Med Assoc J. 1958 Dec 1;79(11):897-8.
5
A study of the clinical effectiveness of a new anorexiant compound: phenmetrazine hydrochloride (preludin).一种新型食欲抑制剂化合物：盐酸苯甲曲秦（普律定）的临床疗效研究。
N Y State J Med. 1958 Jul 15;58(14):2394-6.
6
Phenmetrazine in the management of obesity.
Am J Dig Dis. 1956 Apr;1(4):155-9. doi: 10.1007/BF02233474.
7
Treatment of obesity with phenmetrazine hydrochloride, a new anorexiant.用新型食欲抑制剂盐酸苯甲曲秦治疗肥胖症。
J Am Med Assoc. 1957 Sep 14;165(2):135-8. doi: 10.1001/jama.1957.02980200015005.
8
[Preludin as adjuvant in therapy of orthopedic diseases].[普瑞林作为骨科疾病治疗的辅助药物]
Med Klin. 1957 Jan 18;52(3):100-2.
9
A comparative study of phenmetrazine and dextro-amphetamine in a short-term reducing program in medical students.苯甲曲秦与右旋苯丙胺在医学生短期减肥计划中的对比研究。
Antibiotic Med Clin Ther (New York). 1959 Apr;6(4):207-11.
10
[Preludin and obesity].[苯丙胺与肥胖]
Med Esp. 1957 Jul;38(220):72-9.
引用本文的文献
1
Weight management in obesity - past and present.肥胖症的体重管理——过去与现在
Int J Clin Pract. 2016 Mar;70(3):206-17. doi: 10.1111/ijcp.12771. Epub 2016 Jan 26.
2
Toxic response to 2-phenyl-3-methyl tetrahydro-1, 4-oxidazine hydrochloride (preludin) in humans.人类对盐酸2-苯基-3-甲基四氢-1,4-恶二嗪（哌醋甲酯）的毒性反应。
Psychopharmacologia. 1959 Nov 3;1:124-39. doi: 10.1007/BF00409112.
3
Phenmetrazine hydrochloride; a clinical evaluation of a new anoretic agent.盐酸芬美曲嗪；一种新型食欲抑制剂的临床评估。
Calif Med. 1957 Dec;87(6):408-10.
本文引用的文献
1
[Preliminary trials with a new psychamine (A 66, 2-phenyl-3-methyl-tetrahydro-1,4-oxazine) in the treatment of obesity].[一种新型精神胺（A 66，2-苯基-3-甲基-四氢-1,4-恶嗪）治疗肥胖症的初步试验]
Presse Med (1893). 1955 Aug 20;63(55):1122-3.
Zotero 插件